![Thomas Olson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Olson
Chief Operating Officer at Acesis BioMed US, Inc.
Profile
Mr. Thomas B.
Olson is a Chief Operating Officer & Secretary at Acesis Holdings Corp., a Chief Operating Officer at Acesis BioMed US, Inc. and a Member at Cresthill Associates, LLC.
Thomas Olson active positions
Companies | Position | Start |
---|---|---|
Acesis BioMed US, Inc.
![]() Acesis BioMed US, Inc. Pharmaceuticals: MajorHealth Technology IASO BioMed, Inc. operates as a developmental stage biotechnology company. It focuses on researching and developing a drug. The company founded on March 11, 2015 and is headquartered in Centennial, CO. | Chief Operating Officer | - |
Acesis Holdings Corp.
![]() Acesis Holdings Corp. BiotechnologyHealth Technology Acesis Holdings Corp. functions as an investment holding company whose subsidiaries developing platform of oral drug candidates for metabolic and endocrine disorders. The company was founded on October 3, 2022 and is headquartered in Lone Tree, CO. | Chief Operating Officer | 2022-10-02 |
Cresthill Associates, LLC | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Cresthill Associates, LLC | |
Acesis BioMed US, Inc.
![]() Acesis BioMed US, Inc. Pharmaceuticals: MajorHealth Technology IASO BioMed, Inc. operates as a developmental stage biotechnology company. It focuses on researching and developing a drug. The company founded on March 11, 2015 and is headquartered in Centennial, CO. | Health Technology |
Acesis Holdings Corp.
![]() Acesis Holdings Corp. BiotechnologyHealth Technology Acesis Holdings Corp. functions as an investment holding company whose subsidiaries developing platform of oral drug candidates for metabolic and endocrine disorders. The company was founded on October 3, 2022 and is headquartered in Lone Tree, CO. | Health Technology |
- Stock Market
- Insiders
- Thomas Olson